BioSpace News Archive

Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application

Cients may choose from a more diversified portfolio of manufacturing options.

August 12, 2019
·
3 min read
Drug Development

Cellect Biotechnology Announces Positive Outcome From Safety Review Committee; Successfully Transplants 9th Clinical Trial Patient

Solid progress as Washington University’s Scientific Review Committee Approved the Company’s First U.S. Study

August 12, 2019
·
5 min read
Genetown

Bruker Announces Quarterly Dividend Paid September 20, 2019

The dividend will be paid on September 20, 2019 to stockholders of record as of September 3, 2019.

August 12, 2019
·
1 min read
Business

Oncologie, Inc. Announces Clinical Trial Collaboration With Merck to Evaluate Bavituximab in Combination With KEYTRUDA® (Pembrolizumab) in Advanced Gastric or Gastroesophageal Cancer

The study is expected to enroll approximately 80 patients in the U.S., United Kingdom, Korea and Taiwan.

August 12, 2019
·
2 min read
Business

Akero Therapeutics Reports Recent Highlights and Second Quarter 2019 Financial Results

Advanced AKR-001 into Phase 2a BALANCED clinical study in NASH

August 12, 2019
·
7 min read
BioCapital

CASI Pharmaceuticals Announces Launch of EVOMELA® (melphalan for injection) in China

It is the only approved and commercially available melphalan product in China.

August 12, 2019
·
6 min read
Drug Development

Kedrion Biopharma Announces First Patient Enrolled in CARES10, a Phase 3, Multi-Center Study to Assess a 10 Percent Intravenous Immunoglobulin in Adults with Primary Immunodeficiency Disease

CARES10 is expected to yield pivotal data that will be used in a biologics license application (BLA) submission to FDA.

August 12, 2019
·
4 min read
Business

Mevion and C-RAD Release Integration for Improved Treatment Quality in Proton Therapy

The union of both products supports a seamless workflow with uninterrupted patient surface tracking and monitoring from setup through treatment.

August 12, 2019
·
3 min read
Genetown

TScan Therapeutics Announces Pioneering Publication in Scientific Journal Cell Describing New Methods to Identify Targets for T Cell Receptor Immunotherapy

The TScan Platform enables discovery of novel TCR Immunotherapies for cancer and infectious diseases

August 12, 2019
·
3 min read
Business

Rite Aid Appoints Heyward Donigan as Chief Executive Officer

As planned, John Standley will step down from his role as chief executive officer in connection with this announcement.

August 12, 2019
·
4 min read